Showing results (1021-1030 of 1,275) with videos related to

Sort By:
Pageof 128
Veterinary and Comparative Oncology|September 4, 2025
Favourable Prognostic Significance of HER2 Mutations in Canine Pulmonary Adenocarcinoma Following Surgical ResectionMasanao Ichimata, Yumiko Kagawa, Atsushi Toshima, et al.
Veterinary and Comparative Oncology|February 22, 2023
A retrospective study of canine oral extramedullary plasmacytoma over a 15-year period (July 2004-July 2019): Treatment, histologic parameters and clinical outcomesJanny V Evenhuis, Andrew Oates, Naomi Hoyer, et al.
Veterinary and Comparative Oncology|October 11, 2016
Pretreatment leukocyte ratios and concentrations as predictors of outcome in dogs with cutaneous mast cell tumoursO Skor, A Fuchs-Baumgartinger, A Tichy, et al.
Veterinary and Comparative Oncology|March 22, 2017
Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cellsG B Gelaleti, T F Borin, L B Maschio-Signorini, et al.
Veterinary and Comparative Oncology|January 26, 2017
Potency and stability of compounded formulations of chlorambucil, melphalan and cyclophosphamideJ H Burton, H K Knych, S D Stanley, et al.
Veterinary and Comparative Oncology|October 26, 2016
Transcriptome analysis of equine sarcoidsE Semik, A Gurgul, T Ząbek, et al.
Veterinary and Comparative Oncology|February 11, 2017
Characteristics of extracellular cyclic AMP-dependent protein kinase as a biomarker of cancer in dogsD H Bhang, U S Choi, B G Kim, et al.
Veterinary and Comparative Oncology|February 15, 2017
Furosemide for prevention of cyclophosphamide-associated sterile haemorrhagic cystitis in dogs receiving metronomic low-dose oral cyclophosphamideL Setyo, M Ma, T Bunn, et al.
Veterinary and Comparative Oncology|October 4, 2016
A literature review of reports of the stability and storage of common injectable chemotherapy agents used in veterinary patientsC M Chan, A E Frimberger, A S Moore
Veterinary and Comparative Oncology|September 2, 2022
The mitotic regulator polo-like kinase 1 as a potential therapeutic target for c-Myc-overexpressing canine osteosarcomasCecilia Gola, Luca Licenziato, Paolo Accornero, et al.
Pageof 128